Low virulent infectious salmon anaemia virus (ISAV-HPR0) is prevalent and geographically structured in Norwegian salmon farming.

Infectious salmon anaemia (ISA) is a severe disease in farmed Atlantic salmon Salmo salar that has caused epidemic outbreaks in most salmon-producing countries worldwide. The disease is caused by virulent ISA virus (ISAV). Low virulent variants of the virus, characterised by a full-length sequence in the highly polymorphic region of segment 6 in the virus genome, have been reported with increasing frequencies. These variants of the virus, termed HPR0, have been proposed to be ancestors of virulent ISAV. We examined this idea through studies of the phylogeographic and environmental distribution of ISAV-HPR0, as well as phylogeographic associations between virulent ISAV and ISAV-HPR0. Samples from 232 fish groups were screened for ISAV. Real-time RT-PCR was used for detection of ISAV, and the ISAV haemagglutinin esterase (HE) gene was characterised for positive samples. A Mantel test was used to test phylogeographic associations between pairs of ISAV-HPR0 HE gene sequences. A rank test was used to test associations between HE gene sequences from virulent ISAV and ISAV-HPR0. ISAV-HPR0 was detected in fish groups both in freshwater and marine environments, and in juveniles, on-grown marine salmon and broodstock salmon. Genetic and geographic distances between pairs of ISAV-HPR0 HE gene sequences were positively correlated, suggesting that the population of ISAV-HPR0 is geographically structured. Finally, we found a spatial association between fish groups with virulent ISAV (n = 21) and fish groups with ISAV-HPR0 (n = 27), supporting the hypothesis that ISAV-HPR0 may undergo a transition to virulent ISAV.

Modelling sources of variation and risk factors for spinal deformity in farmed Atlantic salmon using hierarchical- and cross-classified multilevel models.

Sources of variation and risk factors for spinal deformity were investigated in a 2002-2004 year-class database of farmed Atlantic salmon using multilevel modelling. The prevalence of spinal deformity, recorded on subsamples of Atlantic salmon at individual days of harvest, was used as the outcome variable in the study. The dataset consisted of a multilevel structure with days of harvest (n=1441) nested within sea water pens (n=544), which were nested within sea water sites (n=39), which again were cross-classified with fresh water plants (n=21). A four level combined hierarchical- and cross-classified linear mixed model was built in MLwiN using Markov chain Monte Carlo (MCMC) estimation of variance components and fixed effects. Results revealed that a large part of the variance could be explained as sampling and classification random errors, accounting for 32% of the variation in the random intercept model and 41% of the variation in the final mixed effect model. Of the remaining "biological variation" in the random intercept model, 33% was explained by fixed effects where both the use half-year and 1.5 year old photo-manipulated autumn smolts (compared to using one year old spring smolt), and the use of six component vaccines (compared to using four and five component vaccines), were significantly associated with spinal deformity. The results suggest that the physiological changes at time of smoltification make Atlantic salmon susceptible to stressors causing vertebral deformation and that this is most evident in photo-manipulated fish smoltifying when temperature and growth is at its peak. The study further shows the potential of using multilevel modelling in epidemiological studies based on data from industrial aquaculture.

Ten years of bovine virus diarrhoea virus (BVDV) control in Norway: a cost-benefit analysis.

A retrospective cost-benefit analysis was carried out on the Norwegian bovine virus diarrhoea (BVD) control and eradication strategy, for the years 1993-2003. Information regarding the control cost input parameters was gathered from the cattle industry (TINE Norwegian Dairies, GENO Breeding and AI association, and GILDE Norwegian Meat), The National Animal Health Authorities and The Veterinary Institute. We accounted for variable costs (both direct costs associated with the control, and those costs carried by the farmers as a consequence of the control program). The benefit was estimated as the difference between the assumed losses without control - represented overall as 10% increase of the observed 1993 BVD virus infection level - and the observed losses during the control period. An estimate of the financial losses associated with the BVD virus (BVDV) infection was based on studies of the herd level effects on health, reproduction, and production in dairy herds with evidence of recent BVDV infection. We used a stochastic simulation model to account for the total uncertainty in both the control cost and financial loss estimates. The annual net benefits over the 10 years of BVD control were discounted to a 1993 net present value (NPV). The median NPV of the BVD control, nationally, was estimated at 130 million NOK with a distribution of the NPV ranging from +51 to +201 million NOK (5th and 95th percentiles, respectively). Out of the total control costs the farmers and the farmer-owned industries (the co-operatives) had carried about 62% of these costs; however, the farmers were also the main beneficiaries. The Norwegian experience shows a robust cost-efficiency for a BVDV eradication strategy; this stands in sharp contrast to earlier studies where the results were not supportive. Even though every cattle population and country is unique, the Norwegian findings and experiences should have wider implications.